Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients

Sertraline is an (SSRI-)antidepressant metabolized by the polymorphic CYP2C19 enzyme. The aim of this study was to investigate the impact of CYP2C19 genotype on the serum concentrations of sertraline in a large patient population. Second, the proportions of patients in the various CYP2C19 genotype-d...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuropsychopharmacology
Egile Nagusiak: Bråten, Line S., Haslemo, Tore, Jukic, Marin M., Ingelman-Sundberg, Magnus, Molden, Espen, Kringen, Marianne K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6969041/
https://ncbi.nlm.nih.gov/pubmed/31649299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-019-0554-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak